Last updated on July 2020

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy

Find a site near you

Start Over

Local Institution

Kishiwada shi, Japan
  Connect »

Local Institution

Sakai-shi, Japan
  Connect »

Local Institution

Hirakata-shi, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.